Investigating how NSD3 affects lung cancer development
Role of NSD3 in regulation of cancer pathogenesis
This study is looking at a protein called NSD3 to see how it affects the growth of lung squamous cell carcinoma, a serious type of lung cancer, with the hope of finding new treatments that could help patients like you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tx Md Anderson Can Ctr NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11045092 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of the NSD3 protein in the development of lung squamous cell carcinoma (LUSC), a common and deadly form of lung cancer. By studying how NSD3 influences cancer progression at the molecular level, the researchers aim to identify new therapeutic targets that could lead to effective treatments. The study utilizes advanced mouse models that mimic human cancer to explore the mechanisms by which NSD3 contributes to tumor growth and metastasis. Patients may benefit from the findings as they could lead to the development of targeted therapies for LUSC, which currently lacks approved treatment options.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with lung squamous cell carcinoma who may benefit from novel therapeutic approaches.
Not a fit: Patients with other types of lung cancer or those without a diagnosis of lung cancer may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new targeted therapies for lung squamous cell carcinoma, improving treatment options for patients.
How similar studies have performed: Previous research has shown promise in targeting epigenetic factors in cancer treatment, suggesting that this approach could be beneficial.
Where this research is happening
Houston, United States
- University of Tx Md Anderson Can Ctr — Houston, United States (Active)
Researchers
- Principal investigator: Mazur, Pawel K. — University of Tx Md Anderson Can Ctr
- Study coordinator: Mazur, Pawel K.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.